title: Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider.
authors.forename: Samantha L
authors.initials: SL
authors.lastname: Bowker
authors.forename: Sumit R
authors.initials: SR
authors.lastname: Majumdar
authors.forename: Paul
authors.initials: P
authors.lastname: Veugelers
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Johnson
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000401:mortality*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000401:mortality*; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
chemical_list: D007328:Insulin; D013453:Sulfonylurea Compounds